CC
LLY icon

Cedar Capital’s Eli Lilly LLY Stock Holding History

Cedar Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,788
Closed -$294K – 185
2020
Q2 		$294K Sell
1,788
-165
-8% -$25.3K 0.11% 149
2020
Q1 		$271K Buy
1,953
+274
+16% +$37.6K 0.13% 130
2019
Q4 		$221K Sell
1,679
-983
-37% -$114K 0.1% 172
2019
Q3 		$298K Buy
2,662
+203
+8% +$22.6K 0.14% 143
2019
Q2 		$272K Buy
2,459
+367
+18% +$43.2K 0.12% 148
2019
Q1 		$271K Buy
2,092
+355
+20% +$43.2K 0.12% 144
2018
Q4 		$201K Buy
+1,737
New +$194K 0.1% 141

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cedar Capital's LLY Position: Q3 2020 in Review

Cedar Capital sold out of Eli Lilly (LLY) in Q3 2020, closing a stake of 1,788 shares — an estimated $294K sold.

Cedar Capital first reported a position in LLY in Q4 2018 and held it in 7 quarters. The position peaked at $298K in Q3 2019. 1,773 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

  • Cedar Capital reported no remaining Eli Lilly position as of Q3 2020 after selling out during the quarter.
  • Cedar Capital sold 1,788 Eli Lilly shares in Q3 2020, an estimated $294K.
  • Cedar Capital first reported a position in Eli Lilly in Q4 2018 and held it in 7 quarters.
  • Cedar Capital's Eli Lilly position peaked at $298K in Q3 2019.
  • 1,773 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on Cedar Capital's 13F filing for Q3 2020, filed 27 Oct 2020.